Clinical Trials · NCT00393718
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 400
- Start date
- Nov 2006
- Locations
- 1 site, Japan
- Primary endpoint
- Glycosylated Haemoglobin A1c (HbA1c) After 24 Weeks of Treatment